Back to results
US 2024/0199541 A9Published application
Processes to produce brivaracetam
AssigneeSuzhou Pengxu Pharmatech Co., Ltd.
InventorsPeng WANG, Pixu LI, Qiang WEI, Yuanhua LIU
Life of this patent
Estimating the term…
Abstract
The present invention provides a scalable synthesis of enantiomerically pure brivaracetam, and related derivatives.
Claims9
A process for the preparation of brivaracetam XII from VII
- wherein R1 is H, saturated or unsaturated C1-20 alkyl or C1alkyl-unsubstituted or substituted aryl;
- and X is Cl, Br, I, OMs, OTs, ONs.
A process for the preparation of VII from VI
- comprising the step of
- a) converting the compound of the formula VI to the compound of formula VII in the presence of a solvent and TMSI, TMSBr, HBr, HCl or Hl;
- or
- b) ring-opening of the compound of the formula VI and hydrolysis under basic conditions in a solvent, followed by esterification and a reaction with sulfonyl chloride, wherein the sulfonyl chloride is selected from the group consisting of MsCl, TsCl, and NsCl, to obtain the compound of formula VII;
- wherein R1 is saturated or unsaturated C1-20 alkyl or C1alkyl-unsubstituted or substituted aryl;
- and X is Cl, Br, I, OMs, OTs, or ONs.
3 more elements
A process for preparation of the compound of formula XII (brivaracetam), which comprises the step of reacting the compound of formula VI with (S)-2-aminobutanamide to produce the compound of formula XII (brivaracetam).
A compound of formula VII:
- wherein R1 is H or saturated or unsaturated C1-20 alkyl or C1alkyl-unsubstituted or substituted aryl, and X is Cl, Br, I, OMs, OTs, ONs, with the proviso that if R1 is H, X is not I.
A compound of formula IX:
- wherein R1 is saturated or unsaturated C1-20 alkyl or C1alkyl-unsubstituted or substituted aryl.
A substantially pure compound VII:
- wherein R1 is H, and X is I.
Dependencies are inferred from the claim text.